← FDA DRUG APPROVALS

FDA ANDA · ANDA203729

QUININE SULFATE

quinine

Sponsor: AMNEAL PHARMS

APPLICATION
ANDA203729
TYPE
ANDA
ORIGINAL APPROVAL
2015-07-15
LATEST ACTION
2019-12-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

QUININE SULFATEPrescription
QUININE SULFATE 324MG · CAPSULE · ORAL

Approval history

2019-12-13Labeling · Supplement 2 · standardAP
2015-07-15UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →